Publications
5674 Results
- Journal / Conference
- Nature Communications 2016 Apr 7;7:10979. doi: 10.1038/ncomms10979
- Year
- 2016
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID27052111
- PMC
- PMC4829663
- Study Number(s)
- S0000
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation
- Journal / Conference
- Oncotarget 2016 Oct 11;7(41):66328-66343; 2016 Aug 1[Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID27579533
- PMC
- PMC5340084
- Study Number(s)
- S0000
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21
- Journal / Conference
- Leukemia & Lymphoma Feb;58(2):461-465; 2016 Jul 7:1-5. [Epub ahead of print] [print in 2017]
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID27386786
- PMC
- PMC5130311
- Study Number(s)
- S0816
Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin Lymphoma (HL): a sub-analysis of SWOG S0816 phase 2 trial
- Journal / Conference
- World Lung Cancer Conference (Dec 4-7, 2016,Vienna, Austria); oral MA11.06
- Year
- 2016
- Research Committee(s)
- Lung
- Study Number(s)
- S0124
Impact of platinum-sensitivity status on post-progression survival (PPS) of patients with extensive stage small cell lung cancer (ES-SCLC): results from SWOG 0124, a phase III trial of irinotecan/cisplatin(IP) vs. etoposide/cisplatin(EP)
- Journal / Conference
- Journal of Clinical Oncology 34, 2016 (suppl; abstr 505); American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), oral
- Year
- 2016
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8814, SWOG-8897
Predictors of recurrence during years 5-14 in 46,138 women with ER+ breast cancer allocated 5 years only of endocrine therapy (ET)
- Journal / Conference
- Journal of Clinical Oncology 34, 2016 (suppl; abstr LBA5503);American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), oral
- Year
- 2016
- Research Committee(s)
- Gynecologic
- Study Number(s)
- OV21
OV21/PETROC: A randomized Gynecologic Cancer Intergroup (GCIG) phase II study of intraperitoneal (IP) versus intravenous (IV) chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer (EOC)
- Journal / Conference
- American Society of Human Genetics Meeting (Oct 18-22, 2016, Vancouver, BC), poster presentation
- Year
- 2016
- Research Committee(s)
- Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000, SWOG-9217
A Genetic Contribution to Prostate Cancer Incidence in Men of African Ancestry
- Journal / Conference
- San Antonio Breast Cancer Symposium (Dec 6-10, 2016, San Antonio, TX), oral, #S3-05
- Year
- 2016
- Research Committee(s)
- Breast
Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer
- Journal / Conference
- Blood Advances Dec 1(3):250-259
- Year
- 2016
- Research Committee(s)
- Leukemia
- PMID
- PMID29046900
- PMC
- PMC5642915
- Study Number(s)
- S0805